The prevalence and correlates of breast cancer among women in Eastern China

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Yu, Zhi Gang ^a   Jia, Cun Xian ^b,c   Liu, Li Yuan ^b   Geng, Cui Zhi ^d   Tang, Jin Hai ^e   Zhang, Jin ^f   Zhang, Qiang ^a   Li, Yu Yang ^a   Ma, Zhong Bing ^a  

^a THE SECOND HOSPITAL OF SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

^c BUFFALO STATE COLLEGE   (United States)

^d HEBEI MEDICAL UNIVERSITY   (China)

^e JIANGSU CANCER HOSPITAL   (China)

^f KEY LABORATORY OF CANCER PREVENTION AND THERAPY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BODY MASS; BREAST CANCER; BREAST FEEDING; BREAST TUMOR; CANCER RISK; CHINA; CONFIDENCE INTERVAL; CORRELATION ANALYSIS; DIABETES MELLITUS; FAMILY HISTORY; FEMALE; GARLIC; HIGH RISK BEHAVIOR; HUMAN; LIFE SATISFACTION; MAJOR CLINICAL STUDY; MEDICAL HISTORY; MENARCHE; MENOPAUSE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PARITY; PREMENOPAUSE; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; SOCIAL STATUS; SPONTANEOUS ABORTION; URBAN RURAL DIFFERENCE;

ADULT; AGED; BREAST NEOPLASMS; CHINA; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MIDDLE AGED; PREVALENCE; QUESTIONNAIRES; RISK FACTORS;

EID: 84862490976     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0037784     Document Type: Article

References (36)

1. 10 February (2010) WHO The Global Burden of Disease 2004 update. Accessed http://www.who.int/healthinfo/global_burden_disease/2004_report_update/en/index.html.
2. 10 February (2010) Breast cancer: Statistics on incidence,survival and screening. Accessed http://www.imaginis.com/breasthealth/statistics.asp.2008.2.1.
3. Zhang BN, Cao XC, Chen JY, Chen J, Fu L, et al. (2012) Guidelines on the diagnosis and treatment of breast cancer (2011 edition). Gland Surg 1: 39-61.
4. Li HJ, (2007) Analysis on the Breast Cancer Census among 36,433 Married Women" Chin Rural Health Serviced Administration 7: 556-557 the prevalence of breast cancer was 201/100,000 among women aged 45-50 years.
5. Tao HL, He ZX, Liu MY, Xu T, Shen NC, et al. (2009) Screening and Epidemiological Survey of Breast Diseases among 41,256 Women of Child-bearing Period in Urban Communities in Zhuhai City. Chin Oncol 18: 446-448.
6. Hao YY, (2005) Survey Report on Breast Cancer among Some Women in Bozhou, Xinjiang, from 1999 to 2003. Endemic Dis Bull 20: 38-39.
7. Papademetriou K, Ardavanis A, Kountourakis P, (2010) Neoadjuvant therapy for locally advanced breast cancer: Focus on chemotherapy and biological targeted treatments' armamentarium. J Thorac Dis 2: 160-170.
8. Xu Y, Sun Q, (2010) Headway in resistance to endocrine therapy in breast cancer. J Thorac Dis 2(3): 171-177.
9. (2009) Horner MJ RL, Krapcho M, Neyman N, Aminou R, Howlader N,et al. SEER Cancer Statistics Review, 1975-2006. National Cancer Institute. Bethesda. http://seer.cancer.gov/csr/1975_2006/based on November 2008 SEER data submission, posted to the SEER web site.
10. Society AC (2005) Breast Cancer Facts & Figures 2009-2010. http://www.cancer.org/docroot/STT/content/STT_1x_Breast_Cancer_Facts_Figures_09_10_2010.asp. Accessed 10 February 2010.
11. Li J, Zhang BN, Fan JH, Pang Y, Zhang P, et al. (2011) A nation-wide multicenter 10-year (1999-2008) retrospective clinical epidemiological study of female breast cancer in China. BMC Cancer 11: 364.
12. Han DF, Ma J, Zhou X, Qiu H, Fang L, et al. (2004) A case-control study on the risk of female breast cancer in Wuhan area. Zhonghua Liu Xing Bing Xue Za Zhi 25: 256-260.
13. Feigelson HS, Jonas CR, Teras LR, Thun MJ, Calle EE, (2004) Weight gain, body mass index, hormone replacement therapy, and postmenopausal breast cancer in a large prospective study. Cancer Epidemiol Biomarkers Prev 13: 220-224.
14. Daling JR, Malone KE, Doody DR, Voigt LF, Bernstein L, et al. (2003) Association of regimens of hormone replacement therapy to prognostic factors among women diagnosed with breast cancer aged 50-64 years. Cancer Epidemiol Biomarkers Prev 12: 1175-1181.
15. Horn-Ross PL, Canchola AJ, West DW, Stewart SL, Bernstein L, et al. (2004) Patterns of alcohol consumption and breast cancer risk in the California Teachers Study cohort. Cancer Epidemiol Biomarkers Prev 13: 405-411.
16. Vachon CM, Sellers TA, Vierkant RA, Wu FF, Brandt KR, (2002) Case-control study of increased mammographic breast density response to hormone replacement therapy. Cancer Epidemiol Biomarkers Prev 11: 1382-1388.
17. Pike MC, Kolonel LN, Henderson BE, Wilkens LR, Hankin JH, et al. (2002) Breast cancer in a multiethnic cohort in Hawaii and Los Angeles: risk factor-adjusted incidence in Japanese equals and in Hawaiians exceeds that in whites. Cancer Epidemiol Biomarkers Prev 11: 795-800.
18. Valerie B, Diana B, Richard D, Richard P, Gillian R, et al. (2002) Beast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the disease. Lancet 360: 187-195.
19. Zheng W, Xie D, Cerhan JR, Sellers TA, Wen W, et al. (2001) Sulfotransferase 1A1 polymorphism, endogenous estrogen exposure, well-done meat intake, and breast cancer risk. Cancer Epidemiol Biomarkers Prev 10: 89-94.
20. Lahmann PH, Hoffmann K, Allen N, van Gils CH, Khaw KT, et al. (2004) Body size and breast cancer risk: findings from the European Prospective Investigation into Cancer And Nutrition (EPIC). Int J Cancer 111: 762-771.
21. Brind J, Chinchilli VM, Severs WB, Summy-Long J, (1996) Induced abortion as an independent risk factor for breast cancer: a comprehensive review and meta-analysis. J Epidemiol Community Health 50: 481-496.
22. Pike MC, Henderson BE, Casagrande JT, Rosario I, Gray GE, (1981) Oral contraceptive use and early abortion as risk factors for breast cancer in young women. Br J Cancer 43: 72-76.
23. Brewster DH, Stockton DL, Dobbie R, Bull D, Beral V, (2005) Risk of breast cancer after miscarriage or induced abortion: a Scottish record linkage case-control study. J Epidemiol Community Health 59: 283-287.
24. Couzin J, (2003) Cancer risk. Review rules out abortion-cancer link. Science 299: 1498.
25. Michels KB, Xue F, Colditz GA, Willett WC, (2007) Induced and spontaneous abortion and incidence of breast cancer among young women: a prospective cohort study. Arch Intern Med 167: 814-820.
26. Wang Q, Li L, Zhu W, Xing X, Zhou Y, (2000) Study on risk factors of breast cancer among urban women in China. Zhonghua Liu Xing Bing Xue Za Zhi 21: 216-220.
27. McPherson K, Steel CM, Dixon JM, (2000) ABC of breast diseases. Breast cancer-epidemiology, risk factors, and genetics. BMJ 321: 624-628.
28. Collaborative Group on Hormonal Factors in Breast Cancer (2011) Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease. Lancet 358: 1389-1399.
29. Chen WY, Hankinson SE, Schnitt SJ, Rosner BA, Holmes MD, et al. (2004) Association of hormone replacement therapy to estrogen and progesterone receptor status in invasive breast carcinoma. Cancer 101: 1490-1500.
30. Gajalakshmi CK, Shanta V, (1991) Risk factors for female breast cancer. A hospital-based case-control study in Madras, India. Acta Oncol 30: 569-574.
31. Fang Y HH, (2009) The Risk Factors and Their Changes in Breast Cancer. Chin J Health Stat 26: 241-246.
32. Cole P, Mark Elwood J, Kaplan SD, (1978) Incidence rates and risk factors of benign breast neoplasms. Am J Epidemiol 108: 112-120.
33. La Vecchia C, Giordano SH, Hortobagyi GN, Chabner B, (2011) Overweight, obesity, diabetes, and risk of breast cancer: interlocking pieces of the puzzle. Oncologist 16: 726-729.
34. Larsson SC, Mantzoros CS, Wolk A, (2007) Diabetes mellitus and risk of breast cancer: a meta-analysis. Int J Cancer 121: 856-862.
35. Liao S, Li J, Wang L, Zhang Y, Wang C, (2010) Type 2 diabetes mellitus and characteristics of breast cancer in China. Asian Pac J Cancer Prev 11: 933-937.
36. Alokail MS, Al-Daghri NM, Al-Attas OS, Hussain T, (2009) Combined effects of obesity and type 2 diabetes contribute to increased breast cancer risk in premenopausal women. Cardiovasc Diabetol 8: 33.